Lightweight breast implants: a novel solution for breast augmentation and reconstruction mammaplasty.
Breast augmentation and reconstruction mammaplasty have been in practice for decades and are highly prevalent surgeries performed worldwide. While overall patient satisfaction is high, common long-term effects include breast tissue atrophy, accelerated ptosis and inframammary fold breakdown. Increasing evidence attributes these events to the durative loading and compressive forces introduced by the breast implants. Mechanical challenges exceeding the elastic capacity of the breast tissue components, eventually lead to irreversible tissue stretching, directly proportional to the introduced mass. Thus, it is suggested that, contrary to long-standing dogmas, implant weight, rather than its volume, stands at the basis of future tissue compromise and deformation. A novel lightweight implant has been developed to address the drawbacks of traditional breast implants, which demonstrate equivalence between their size and weight. The B-Lite(®) breast implant (G&G Biotechnology Ltd., Haifa, Israel) design allows for a reduction in implant weight of up to 30%, while maintaining the size, form, and function of traditional breast implants. The CE-marked device can be effectively implanted using standard of care procedures and has been established safe for human use. Implantation of the B-Lite(®) breast implant is projected to significantly reduce the inherent strains imposed by standard implants, thereby conserving tissue stability and integrity over time. In summary, this novel, lightweight breast implant promises to reduce breast tissue compromise and deformation and subsequent reoperation, further improving patient safety and satisfaction.
Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Jacky
J
Govrin-Yehudain
Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Haim
H
Dvir
Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Dina
D
Preise
Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Orel
O
Govrin-Yehudain
Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Dael
D
Govreen-Segal
D000328:Adult; D000368:Aged; D019928:Breast Implantation / Q000009:adverse effects / Q000379:methods*; D018427:Breast Implants; D004954:Esthetics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016462:Mammaplasty / Q000009:adverse effects / Q000379:methods*; D008875:Middle Aged; D011474:Prosthesis Design / Q000379:methods*; D011475:Prosthesis Failure; D018570:Risk Assessment; D016896:Treatment Outcome; D014894:Weights and Measures